We are live on ! Find out more
MWNA

Marshall Wace North America Portfolio holdings

AUM $23.5B
1-Year Est. Return 46.46%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+46.46%
3 Year Est. Return
+109.4%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$20.7B
AUM Growth
+$3.14B
Cap. Flow
+$1.47B
Cap. Flow %
7.1%
Top 10 Hldgs %
15.76%
Holding
1,778
New
496
Increased
377
Reduced
371
Closed
524

Top Buys

Rank Stock Value
1
HCA icon
HCA Healthcare
HCA
+$221M
2
GDDY icon
GoDaddy
GDDY
+$159M
3
CI icon
Cigna
CI
+$135M
4
PFE icon
Pfizer
PFE
+$132M
5
HOLX
Hologic
HOLX
+$98.3M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$156M
2
AAPL icon
Apple
AAPL
+$148M
3
MSFT icon
Microsoft
MSFT
+$126M
4
MCD icon
McDonald's
MCD
+$121M
5
DHR icon
Danaher
DHR
+$107M

Sector Composition

Rank Sector Weight
1 Healthcare 25.95%
2 Technology 21.4%
3 Consumer Discretionary 12.43%
4 Industrials 11.77%
5 Financials 6.59%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
COLL icon
601
Collegium Pharmaceutical
COLL
$956M
$1.8M 0.01%
87,455
-18,036
-17% -$301K
NWG icon
602
NatWest
NWG
$76.4B
$1.8M 0.01%
259,109
-182,493
-41% -$1.14M
MNRL
603
DELISTED
Brigham Minerals, Inc. Class A Common Stock
MNRL
$1.78M 0.01%
82,964
+80,874
+3,870% +$1.57M
FMX icon
604
Fomento Económico Mexicano
FMX
$41.7B
$1.75M 0.01%
+18,502
New +$1.7M
ACB
605
Aurora Cannabis
ACB
$185M
$1.74M 0.01%
+6,712
New +$2.5M
LIN icon
606
Linde
LIN
$226B
$1.74M 0.01%
+8,162
New +$1.64M
RGP icon
607
Resources Connection
RGP
$145M
$1.73M 0.01%
105,642
+64,666
+158% +$983K
NDLS icon
608
Noodles & Co
NDLS
$107M
$1.67M 0.01%
37,667
-12,184
-24% -$538K
AVT icon
609
Avnet
AVT
$7.92B
$1.66M 0.01%
39,089
+30,238
+342% +$1.25M
CNI icon
610
Canadian National Railway
CNI
$76.6B
$1.66M 0.01%
18,300
-21,900
-54% -$1.97M
PCG icon
611
PG&E
PCG
$38.5B
$1.66M 0.01%
+152,218
New +$1.3M
TNDM icon
612
Tandem Diabetes Care
TNDM
$1.56B
$1.66M 0.01%
27,763
-158,547
-85% -$9.78M
CBOE icon
613
Cboe Global Markets
CBOE
$29.9B
$1.65M 0.01%
13,781
-119,234
-90% -$14M
LPX icon
614
Louisiana-Pacific
LPX
$5.49B
$1.65M 0.01%
55,626
+13,985
+34% +$395K
RYAM icon
615
Rayonier Advanced Materials
RYAM
$610M
$1.64M 0.01%
428,141
+51,484
+14% +$210K
LIND icon
616
Lindblad Expeditions
LIND
$2.22B
$1.62M 0.01%
99,123
+93,485
+1,658% +$1.49M
PTLA
617
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
$1.62M 0.01%
+67,861
New +$1.87M
ABEO icon
618
Abeona Therapeutics
ABEO
$413M
$1.62M 0.01%
+19,772
New +$1.4M
SUM
619
DELISTED
Summit Materials, Inc. Class A Common Stock
SUM
$1.6M 0.01%
+68,222
New +$1.55M
TTE icon
620
TotalEnergies
TTE
$190B
$1.6M 0.01%
+28,904
New +$1.53M
CTLT
621
DELISTED
CATALENT, INC.
CTLT
$1.6M 0.01%
+28,350
New +$1.45M
EQNR icon
622
Equinor
EQNR
$92.4B
$1.59M 0.01%
79,907
-264,087
-77% -$5M
VG
623
DELISTED
Vonage Holdings Corporation
VG
$1.59M 0.01%
+214,121
New +$1.85M
FSCT
624
DELISTED
ForeScout Technologies, Inc. Common Stock
FSCT
$1.57M 0.01%
47,971
+189
+0.4% +$6.2K
BRY
625
DELISTED
Berry Corp
BRY
$1.56M 0.01%
+165,198
New +$1.54M
23 24
25
26 27

Similar funds

TGHSA
TPG Group Holdings (SBS) Advisors Fort Worth, Texas $10.1B AUM 22.58% 1-Year Est. Return
PAM
PFM Asset Management Harrisburg, Pennsylvania $5.36B AUM 21.04% 1-Year Est. Return
HB
Homrich & Berg Atlanta, Georgia $4.47B AUM 22.61% 1-Year Est. Return
MWA
Marshall Wace Asia Central, Hong Kong $4.23B AUM 69.9% 1-Year Est. Return
3SCA
36 South Capital Advisors London, United Kingdom $3.76B AUM
HFCIV
H&F Corporate Investors VII San Francisco, California $3.61B AUM 26.49% 1-Year Est. Return
DVC
Deer VIII & Co Larchmont, New York $3.56B AUM
NAM
NorthCoast Asset Management Greenwich, Connecticut $2.74B AUM 25.44% 1-Year Est. Return

Marshall Wace North America's Q4 2019 Portfolio in Review

As of Q4 2019, Marshall Wace North America held 1,778 positions worth $20.7B, up 18% from $17.6B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

Marshall Wace North America deployed $1.47B of net new capital in Q4 2019, opening 496 new positions and adding to 377 existing holdings. Its largest new stake was Deere & Co: 519,053 shares worth $89.9M.

By sector, the portfolio is most concentrated in Healthcare at 26% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Gilead Sciences, an estimated $156M trimmed.

  • Marshall Wace North America's largest Q4 2019 buy was Deere & Co: 519,053 shares worth $89.9M.
  • Marshall Wace North America added most to HCA Healthcare in Q4 2019, an estimated $221M increase.
  • Marshall Wace North America's biggest Q4 2019 reduction was Gilead Sciences, cutting an estimated $156M.
  • Marshall Wace North America fully exited McDonald's in Q4 2019, selling an estimated $121M.
  • Marshall Wace North America's ten largest holdings make up 16% of its $20.7B portfolio in Q4 2019.
  • Marshall Wace North America opened 496 new positions and closed 524 in Q4 2019.
  • Marshall Wace North America's portfolio value rose 18% quarter-over-quarter to $20.7B.

Based on Marshall Wace North America's 13F filing for Q4 2019, filed 14 Feb 2020.